Abstract:Abstract A persistent accumulation of damaged mitochondria is part of prion disease pathogenesis. Normally, damaged mitochondria are cleared via a major pathway that involves the E3 ubiquitin ligase parkin and PTEN-induced kinase 1 (PINK1) that together initiate mitophagy, recognize and eliminate damaged mitochondria. However, the precise mechanisms underlying mitophagy in prion disease remain largely unknown. Using prion disease cell models, we observed PINK1-parkin-mediated mitophagy deficiency in which parkin depletion aggravated blocked mitochondrial colocalization with LC3-II-labeled autophagosomes, and significantly increased mitochondrial protein levels, which led to inhibited mitophagy. Parkin overexpression directly induced LC3-II colocalization with mitochondria and alleviated defective mitophagy. Moreover, parkin-mediated mitophagy was dependent on PINK1, since PINK1 depletion blocked mitochondrial Parkin recruitment and reduced optineurin and LC3-II proteins levels, thus inhibiting mitophagy. PINK1 overexpression induced parkin recruitment to the mitochondria, which then stimulated mitophagy. In addition, overexpressed parkin and PINK1 also protected neurons from apoptosis. Furthermore, we found that supplementation with two mitophagy-inducing agents, nicotinamide mononucleotide (NMN) and urolithin A (UA), significantly stimulated PINK1-parkin-mediated mitophagy. However, compared with NMN, UA could not alleviate prion-induced mitochondrial fragmentation and dysfunction, and neuronal apoptosis. These findings show that PINK1-parkin-mediated mitophagy defects lead to an accumulation of damaged mitochondria, thus suggesting that interventions that stimulate mitophagy may be potential therapeutic targets for prion diseases.

PINK1 Kinase Dysfunction Triggers Neurodegeneration in the Primate Brain Without Impacting Mitochondrial Homeostasis

A CRISPR monkey model unravels a unique function of PINK1 in primate brains

Comparative Analysis of Primate and Pig Cells Reveals Primate-Specific PINK1 Expression and Phosphorylation.

Differential Distribution of PINK1 and Parkin in the Primate Brain Implies Distinct Roles

Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons

Loss of PINK1 causes age-dependent mitochondrial trafficking deficits in nigrostriatal dopaminergic neurons through aberrant activation of p38 MAPK

The Parkinson's disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1.

Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models

Pink1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit And Alpha-Synuclein Aggregation In Cell Culture Models Of Parkinson'S Disease

Basal activity of PINK1 and PRKN in cell models and rodent brain

PINK1 gene mutation by pair truncated sgRNA/Cas9-D10A in cynomolgus monkeys

PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models

PINK1 regulates mitochondrial fission/fusion and neuroinflammation in β-amyloid-induced Alzheimer's disease models

Mitochondrial-Dependent and Independent Functions of PINK1

PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling

Loss of PINK1 Causes Age-Dependent Decrease of Dopamine Release and Mitochondrial Dysfunction.

PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease

Analysis of Neuronal Phosphoproteome Reveals PINK1 Regulation of BAD Function and Cell Death.

Mutating PINK1 gene by paired truncated sgRNA/Cas9-D10A in Cynomolgus Monkey

PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

Pink1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy